Best Acute lymphoblastic leukemia doctors in Israel: TOP 20 doctors

Dr. Ram Ron works within one of Israel's leading and largest public teaching hospitals, the Sourasky Medical Center (Ichilov), known for its high-level patient care and medical innovation.

• Access to advanced treatments and technologies at a premier university hospital
• Part of a comprehensive, multidisciplinary hematology-oncology team
• Benefits from a center dedicated to both patient care and research
• Works in a hospital accredited by the Joint Commission International

Dr. Ron Ram has performed several hundred stem cell transplants, a key procedure for acute lymphoblastic leukemia, as a board-certified hematologist-oncologist.

• Board-certified in both hematology and medical oncology
• Trained during a Hematology and Oncology fellowship at New York Medical College
• Published over 30 scientific articles on hematologic conditions
• Author of a chapter in a medical textbook

Dr. Ronit El Hasid has performed over 300 bone marrow and umbilical blood transplantations for children at Dana Dwek Children’s Hospital.

• Head of Pediatric Oncohematology and Oncology Department
• 50+ publications and 40+ conference reports
• Member of American Association for Hematology
• Trained at City of Hope Hospital in Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira specializes exclusively in bone marrow transplantation at Sourasky Medical Center – a leader in hematologic treatments.

• Graduated from Hebrew University medical school in 1999
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation at Hadassah
• Fluent in both English and Hebrew

Dr. Dror Levin directs the pediatric hematology oncology department at Sourasky Medical Center in Tel Aviv, one of Israel's top hospitals.

• Senior expert in treating blood disorders and bone cancer in children
• Trained in pediatric oncology at Schneider Children's Medical Center
• Specializes in pediatric hematology, including coagulation disorders in preemies
• Studied sarcoma treatment at the world-renowned Rizzoli Orthopaedic Institute
• Active member of the Israel Society of Pediatric Hemato-Oncology

Dr. Fredi Aviv brings over 34 years of experience of focused practice as an oncohematologist at Tel Aviv's leading Sourasky Medical Center.

• Specializes exclusively in blood cancers like leukemia and lymphoma
• Long-term tenure at a major academic and research hospital
• Offers deep experience with both initial diagnoses and complex treatment plans
• Provides access to the latest hospital-based therapies and clinical trials

Dr. Herishanu has been recognized with multiple prestigious awards for his research into chronic lymphocytic leukemia.

• Over 24 years of experience of medical experience as a hematologist
• Author of numerous published research papers
• Trained in hematology at Tel Aviv Medical Center
• Member of the American and Israeli Hematology Associations

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Professor Zila Zuckerman specializes in hematology and transplantology at Rambam Medical Center.

• Expert in treating acute lymphoblastic leukemia
• Specializes in transplantology for blood disorders
• Professor with extensive academic and clinical experience

Head of Hematology at Hadassah Medical Center – Professor Ben-yehuda pioneered gene therapy and bone marrow transplants for acute lymphoblastic leukemia.

• Trained at Memorial Sloan-Kettering Cancer Center in New York
• First female Dean of Hadassah School of Medicine
• Specializes in molecular diagnostics and immunology
• Recipient of the Healing with the Heart Award for exceptional patient care

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants at Hadassah Medical Center.

• 28 years of experience specializing in pediatric bone marrow transplants
• Focused on rare blood cancer diseases in children
• Known among patients as 'the one who transplants life'
• Leads a dedicated pediatric hematology unit

Dr. Ofer Spielberg is a specialized oncohematologist, focusing on blood cancers like leukemia.

• Practices at Assuta Medical Center
• Expertise in oncohematology, the field dedicated to blood cancers
• Provides targeted treatment for acute lymphoblastic leukemia